Gossamer Bio Inc reports results for the quarter ended in March - Earnings Summary

Gossamer Bio

07/05/2024 23:32

* Gossamer Bio Inc  GOSS.OQ  reported a quarterly adjusted
loss
of 19 cents​​ per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -52 cents.  The mean expectation of nine analysts for the
quarter was for a loss of 19 cents per share. Wall Street
expected results to range from -25 cents to -15 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Gossamer Bio Inc's reported EPS for the quarter was a loss
of 19
cents​.
    * The company reported a quarterly loss of $41.93 million.
    * Gossamer Bio Inc shares had fallen by 33.8% this
quarter and
lost 14.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Gossamer Bio Inc
is $5.00 
This summary was machine generated from LSEG data May 7 at 10:32
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.19          -0.19          Met
 Dec. 31 2023      -0.21          -0.21          Met
 Sep. 30 2023      -0.26          -0.21          Beat
 Jun. 30 2023      -0.49          -0.45          Beat